Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient (Scleroderma)

This study has been completed.
Sponsor:
Information provided by:
Northwell Health
ClinicalTrials.gov Identifier:
NCT00566137
First received: November 29, 2007
Last updated: March 8, 2010
Last verified: March 2010
  Purpose
To determine sleep disturbance, pulmonary function test, 6 minute walk, echocardiogram abnormality, arterial blood gas, ventilation/perfusion scan of the chest in Scleroderma patient with Pulmonary Hypertension.

Condition
Scleroderma
Pulmonary Hypertension

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient

Resource links provided by NLM:


Further study details as provided by Northwell Health:

Enrollment: 50
Study Start Date: February 2006
Study Completion Date: February 2007
Detailed Description:
As above
  Eligibility

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Males, Females and Minorities

Age range of subjects 18-75 years old

Criteria

Inclusion Criteria:

  • Patient must have Scleroderma

Exclusion Criteria:

  • Patients who do not have Scleroderma
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00566137

Sponsors and Collaborators
Northwell Health
Investigators
Principal Investigator: Arunabh Talwar, MD Northwell Health
  More Information

Responsible Party: ARUNABH TALWAR MD, NORTH SHORE- LONG ISLAND HEALTH SYSTEM
ClinicalTrials.gov Identifier: NCT00566137     History of Changes
Other Study ID Numbers: 06-08-018  NS-LIJHS IRB #06-08-018 
Study First Received: November 29, 2007
Last Updated: March 8, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Northwell Health:
Scleroderma
Pulmonary Hypertension

Additional relevant MeSH terms:
Scleroderma, Systemic
Scleroderma, Diffuse
Scleroderma, Localized
Hypertension
Hypertension, Pulmonary
Dyssomnias
Sleep Wake Disorders
Parasomnias
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases
Connective Tissue Diseases
Skin Diseases
Nervous System Diseases
Mental Disorders
Neurologic Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on December 05, 2016